|
|
||||||||
MUSCLE CELL BIOLOGY AND CELL MOTILITY
1Medical Pharmacology and Physiology, College of Medicine, University of Missouri-Columbia; 2Department of Cell Biology and Histology, University of Nijmegen, Nijmegen, The Netherlands; 3Department of Biomedical Sciences, College of Veterinary Medicine; and 4Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri
Submitted 23 November 2004 ; accepted in final form 13 January 2005
The production of AMP by adenylate kinase (AK) and subsequent deamination by AMP deaminase limits ADP accumulation during conditions of high-energy demand in skeletal muscle. The goal of this study was to investigate the consequences of AK deficiency (/) on adenine nucleotide management and whole muscle function at high-energy demands. To do this, we examined isometric tetanic contractile performance of the gastrocnemius-plantaris-soleus (GPS) muscle group in situ in AK1/ mice and wild-type (WT) controls over a range of contraction frequencies (30120 tetani/min). We found that AK1/ muscle exhibited a diminished inosine 5'-monophosphate formation rate (14% of WT) and an inordinate accumulation of ADP (
1.5 mM) at the highest energy demands, compared with WT controls. AK-deficient muscle exhibited similar initial contractile performance (521 ± 9 and 521 ± 10 g tension in WT and AK1/ muscle, respectively), followed by a significant slowing of relaxation kinetics at the highest energy demands relative to WT controls. This is consistent with a depressed capacity to sequester calcium in the presence of high ADP. However, the overall pattern of fatigue in AK1/ mice was similar to WT control muscle. Our findings directly demonstrate the importance of AMP formation and subsequent deamination in limiting ADP accumulation. Whole muscle contractile performance was, however, remarkably tolerant of ADP accumulation markedly in excess of what normally occurs in skeletal muscle.
AMP deaminase; tetanic contraction; muscle relaxation; calcium handling; cross-bridge cycling
This article has been cited by other articles:
![]() |
D. G. Allen, G. D. Lamb, and H. Westerblad Skeletal Muscle Fatigue: Cellular Mechanisms Physiol Rev, January 1, 2008; 88(1): 287 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fischer, M. Esbjornsson, R. L. Sabina, A. Stromberg, M. Peyrard-Janvid, and B. Norman AMP deaminase deficiency is associated with lower sprint cycling performance in healthy subjects J Appl Physiol, July 1, 2007; 103(1): 315 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Hancock, E. Janssen, and R. L. Terjung Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice J Appl Physiol, February 1, 2006; 100(2): 406 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Hancock, J. J. Brault, R. W. Wiseman, R. L. Terjung, and R. A. Meyer 31P-NMR observation of free ADP during fatiguing, repetitive contractions of murine skeletal muscle lacking AK1 Am J Physiol Cell Physiol, June 1, 2005; 288(6): C1298 - C1304. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |